| Literature DB >> 33292015 |
Olgun Göktaş1, Canan Ersoy2, Ilker Ercan3, Fatma Ezgi Can4.
Abstract
BACKGROUND: Vitamin D, along with parathyroid hormone (PTH) and calcitonin, is an important hormone that affects bone and calcium metabolism.Entities:
Keywords: General practice/family medicine; gender; seasonal variation; vitamin D
Year: 2020 PMID: 33292015 PMCID: PMC7733979 DOI: 10.1080/13814788.2020.1846712
Source DB: PubMed Journal: Eur J Gen Pract ISSN: 1381-4788 Impact factor: 1.904
Vitamin D values by gender and seasons.
| Vitamin D (ng/mL) (Overall) | Vitamin D categories | |||||
|---|---|---|---|---|---|---|
| n | Median (min–max) | <20 | ≥20 | |||
| Women | ||||||
| December–February (I) | 2995 | 11 (3–70) | 2294 (76.6%) | 701 (23.4%) | <0.001 | |
| March–May (II) | 2533 | 10.2 (3–140) | 2044 (80.7%) | 476 (19.3%) | ||
| June–August (III) | 1911 | 10.3 (3–140) | <0.001 | 1541 (80.6%) | 357 (19.4%) | |
| September–November (IV) | 1703 | 14.8 (3–140) | 1191 (69.9%) | 491 (30.1%) | ||
| All women | ||||||
| All seasons | 9142 | 12.7 (3–140) | 2344 (25.6%) | 6798 (74.4%) | ||
| Men | ||||||
| December–February (I) | 773 | 19 (3–70) | 429 (55.5%) | 344 (44.5%) | <0.001 | |
| March–May (II) | 746 | 14.8 (3–86.9) | 578 (77.5%) | 163 (22.5%) | ||
| June–August(III) | 553 | 15.4 (3–88) | <0.001 | 393 (71.1%) | 156 (28.9%) | |
| September–November (IV) | 520 | 23.1 (3–71.8) | 171 (32.9%) | 339 (67.1%) | ||
| All men | ||||||
| All seasons | 2592 | 18.2 (3–88) | 1110 (42.8%) | 1482 (57.2%) | ||
| Total | ||||||
| All seasons | 11,734 | |||||
Association of comorbidities on vitamin D levels.
| Accompanying comorbidity | Vitamin D status | ||||
|---|---|---|---|---|---|
| n | <20 (ng/mL) | n | ≥20 (ng/mL) | ||
| Liver disease | 8280 | 48 (0.6%) | 3454 | 18 (0.5%) | 0.699 |
| Renal disease | 8280 | 133 (1.6%) | 3454 | 65 (1.9%) | 0.291 |
| Malabsorbtion | 8280 | 101 (1.2%) | 3454 | 34 (1%) | 0.276 |
| Inflammatory Bowel disease | 8280 | 126 (1.5%) | 3454 | 60 (1.7%) | 0.395 |
| Obesity | 8280 | 123 (1.5%) | 3454 | 38 (1.1%) | 0.102 |
| Type 2 diabetes | 8280 | 197 (2.4%) | 3454 | 113 (3.3%) | 0.006 |
| Hypertension | 8280 | 2352 (28.4%) | 3454 | 1250 (36.2%) | <0.001 |
| Dyslipidemia | 8280 | 1082 (13.1%) | 3454 | 601 (17.4%) | <0.001 |
| Atherosclerotic cardiovascular disease | 8280 | 714 (8.6%) | 3454 | 417 (12.1%) | <0.001 |
| Smokers | 1014 | 8 (0.8%) | 368 | 1 (0.3%) | 0.459 |
| Fracture | |||||
| None (I) | 1102 (85.8%) | 459 (82.9%) | 0.130 | ||
| Bone Fragility (II) | 152 (11.8%) | 74 (13.4%) | |||
| Traumatic (III) | 30 (2.3%) | 21 (3.8%) | |||
Association of laboratory parameters on vitamin D levels.
| Laboratory parameter | Vitamin D status | ||||
|---|---|---|---|---|---|
| <20 (ng/mL) | ≥20 (ng/mL) | ||||
| Calcium, | 2861 | 9.5 (5.2–12.3) | 6653 | 9.4 (6.1–12) | <0.001 |
| Creatinine (mg/dL), Median (min–max) | 7703 | 0.6 (0.1–5.7) | 3250 | 0.7 (0.2–5) | <0.001 |
| ALT (U/L), | 7749 | 15 (1–411) | 3261 | 16 (1–280) | <0.001 |
| AST (U/L), | 7565 | 16 (1–393) | 3205 | 17 (7–144) | <0.001 |
| Glucose (mg/dL), | 7931 | 92 (36–482.5) | 3333 | 92 (43–357) | 0.090 |
| HDL cholesterol (mg/dL), | 6840 | 52 (13–124) | 2992 | 52 (17–145) | 0.257 |
| Total cholesterol (mg/dL), | 7372 | 182 (70–476) | 3165 | 188.5 (74.5–423) | <0.001 |
| LDL cholesterol (mg/dL), | 6723 | 104 (11–372) | 2954 | 109 (16–312) | <0.001 |
| Triglyceride (mg/dL) | 7056 | 114 (22–1613) | 3065 | 113 (28–810) | 0.638 |
| Insulin (mIU/L) | 5342 | 8.7 (0.1–181.5) | 2381 | 7.5 (0.2–146.6) | <0.001 |
| CRP (mg/L), | 6409 | 0.2 (0–31.5) | 2737 | 0.1 (0–24.1) | <0.001 |
| Phosphorus, | 2425 | 3.5 (1.8–7.4) | 5567 | 3.5 (1.4–7.3) | 0.040 |
ALT: alanine aminotransferase; AST: aspartate aminotransferase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; CRP: C-reactive protein.
Determination of factors affecting vitamin D level.
| OR | %95 Confidence interval | ||
|---|---|---|---|
| Gender (Ref: Male) | 8.4 | 3.8–18.4 | <0.001 |
| Milk (Ref: milk and dairy product consumption) | 0.085 | ||
| Dairy product | 2.5 | 0.5–10.8 | 0.220 |
| Milk | 0.1 | 0–1.1 | 0.071 |
| None | 0.7 | 0.2–1.7 | 0.433 |
Model significance: p < 0.001.